CAMPS State Legislative Efforts Pay Off!

Published in Government Relations on July 06, 2022

Last week, the final budget deal was announced and approved by both Houses today. CAMPS pursued multiple reimbursement changes and following reimbursement changes will occur:

  • Makes permanent the 100% of Medicare for all respiratory equipment and supplies that was established by DHCS during the PHE.
  • Eliminates the 10% cut on all DME.
  • Eliminates the 10% cut for Continuous Glucose Monitoring devices.
  • Eliminates the 10% for orthotic devices on 7/1/22 or when federal approval is obtained. Eliminates it for prosthetic services/devices on 1/1/23.

Craig Douglas, VGMs VP of Payer Relations reports, “The positive outcome achieved for our industry outlined herein is a prime example of what we can achieve when we identify a common goal, put our collective voices together, and initiate the necessary conversations with the people who can help us achieve our desired outcomes. When we find ourselves in situations where something is not reflective of our current environment, whether that is a medical policy, a reimbursement rate, etc,, regardless of how long that policy or rate has been in place, we need to point out the insufficiency and work together towards a better outcome. This is exactly what CAMPS did in this situation, working in conjunction with many of their members and other industry stakeholders to accomplish a better outcome.”

Congratulations to CAMPS and all HME suppliers in California for these significant changes! This is how working together as a state association can accomplish positives for all in the industry! If you are not apart of CAMPS or your state association, you need to consider joining.

As posted by CAMPS (California Association of Medical Equipment Product Suppliers)


Final Action on State Budget and
Medi-Cal Changes that Impact You:

Earlier this week the final budget deal was announced and approved by both Houses today. CAMPS pursued multiple reimbursement changes including;

  • Elimination of the current Medi-Cal 10% cut for all DME, Medical supplies and enteral formula
  • Make reimbursement for all DME at 100% of the Medicare rural rate

The Legislature’s version of the budget did in include the elimination of the 10% for all providers/services and 100% of the Medicare rural rate for all respiratory equipment and supplies. Then the final negotiations between Legislative leadership and the Governor occurred behind closed doors to resolve any differences. Unfortunately, the Governor/ Administration did want to provide relief for all providers/services based upon the ongoing fiscal impact and instead expanded the relief to limited provider types. The budget trailer bills AB 184/ SB 184 are the vehicles for the Medi-Cal provisions and were passed today.

It is a mixed bag for us but there is progress and long term benefits, but obviously more to do. The elements of change for us are as follows:

  • Makes permanent the 100% of Medicare for all respiratory equipment and supplies that was established by DHCS during the PHE. We assume it is the Medicare rural rate but will await final announcement. The rural rate is used now and continues during the PHE status which has not changed.
  • Eliminates the 10% cut on all DME. That is an expansion over the Governor’s May Revise which only exempted respiratory equipment and supplies. It does not exempt medical supplies or enteral formula. The elimination of the 10% cut will occur either on 7/1/22 or when CMS approval is provided, whichever is later.
  • Eliminates the 10% cut for Continuous Glucose Monitoring devices.
  • Eliminates the 10% for orthotic devices on 7/1/22 or when federal approval is obtained. Eliminates it for prosthetic services/devices on 1/1/23.

We will notify you of the effective dates once it is clear. We accomplished much this budget cycle but will continue to pursue relief for medical supplies and enteral formula.


TAGS

  1. billing & reimbursement
  2. medicare
  3. reimbursement
  4. state association

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.